Only in specific clinical conditions where concentrations of binding protein concentrations can be significantly altered (i.e. chronic renal failure, starvation), total IGF-I might no longer be the most reliable biomarker ( 60 ). The gene discussed is IGF1; the disease is chronic kidney disease.